Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic review report: Ivabradine hydrochloride (Lancora). Canadian Agency for Drugs and Technologies in Health.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Ivabradine Hydrochloride (Lancora). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Ivabradine Hydrochloride (Lancora). Canadian Agency for Drugs and Technologies in Health, 2017.
Warning: These citations may not always be 100% accurate.